Scientific Programme



     Pre- and Post-Congress Workshops











I think this Congress is unique in
the sense that you get to hear
so many people here in this Academic Medical Centre. It
brings everybody together under
the same umbrella, the roof of Academic Medicine.








~ Prof Victor Dzau 
President, National Academy of Medicine, USA


Programme >

Cancer Immunotherapy Plenary
Evolution of Cancer Immunotherapy

 Track type: Plenary

Date: 22 Sep 2018


 Time: 1215 - 1300

Location: Academia, Level 2, PSL2


Speaker: Dr Ramy Ibrahim


Cancer immunotherapy is now the fourth pillar of anti-cancer therapy with surgery, radiation and systemic therapy including chemotherapy and targeted therapy. It has demonstrated survival benefit in different indications including but not limited to melanoma, NSCLC, SCCHN and RCC. The understanding of how the immune system identifies and attacks cancer has evolved over the years. The focus now is on combining different modalities in order to overcome some of the escape mechanisms.

*Information is correct at time of update